$GEVO

Agiri Oluwagbemileke Yusuf sold $57K of GEVO

Agiri Oluwagbemileke Yusuf (CFO) sold 31,958 shares of Gevo, Inc. (GEVO) at $1.77 on 2026-05-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Agiri Oluwagbemileke Yusuf
Published May 29, 2026, 9:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 29, 2026, 9:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$GEVO
Neutral
medium confidence
Mentioned
$GEVO
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GEVONeutralLow
01

Why it matters

This is a disclosure of an executed sale, not a new company event. The main tradable element is potential short-term sentiment/technical positioning around the filing date.

02

Market read

Traders may monitor GEVO for any follow-through in selling pressure, but the 10b5-1 framing suggests limited informational content.

03

What to watch

The article provides only the sale size/price; it does not indicate whether other insiders/funds are buying, nor any concurrent company-specific news.

Relevance 6/10Novelty 3/10Timing: Disclosure filed May 29; sale executed May 27.

Background

SEC Form 4 reports an officer’s transaction in the issuer’s shares; 10b5-1 indicates the trade was planned in advance.

Company-level read

Ticker impact

$GEVONeutralMedium confidence
Context

Gevo CFO Agiri Oluwagbemileke Yusuf sold 31,958 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Limited, mostly sentiment/positioning impact; watch for follow-on selling or unusual volume around the disclosure window.

Evidence & confidence

The filing is a routine insider transaction and explicitly tied to a pre-arranged 10b5-1 plan, reducing the likelihood of new negative information.

Market effects

Minimal—single-company insider sale without new operational/regulatory catalyst.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with internal risk management or valuation concerns, so traders may still fade strength.

Key entities

  • Gevo, Inc.

    Subject of the insider transaction disclosure (CFO sale under 10b5-1).

  • Agiri Oluwagbemileke Yusuf

    CFO who sold 31,958 shares at $1.7727/share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MURMed

Unpacking Q2 Earnings: Murphy Oil (NYSE:MUR) In The Context Of Other Mixed or Offshore Upstream E&P Stocks

Murphy Oil (NYSE:MUR) reported Q2 revenue of $928.3M, up 33.5% YoY, beating estimates. The stock rose 7% post-earnings. The article also covers other mixed or offshore upstream E&P stocks, including Granite Ridge Resources (NYSE:GRNT), Peabody Energy (NYSE:BTU), Seadrill (NYSE:SDRL), and Gevo (NASDAQ:GEVO), highlighting their Q2 performances and stock movements.

$GEVOMedAI 8/10

Gevo (GEVO) Q2 2026 Earnings Call Transcript

Gevo (GEVO) reported Q2 2026 revenue of $47 million, up 7% year over year, and non-GAAP adjusted EBITDA of $11 million. Full-year 2026 adjusted EBITDA guidance is now above $60 million. The company targets $70 million of 45Z tax credit monetization in 2026 and recorded a $176 million noncash impairment tied to exiting its ATJ-60 project.

$GEVOHigh

Gevo, Inc. (GEVO): Results of Operations and Financial Condition

Gevo, Inc. (GEVO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Gevo Reports Second Quarter Results and Raises Financial Expectations for Full-Year 2026 ENGLEWOOD, Colo. – August 6, 2026 – Gevo, Inc. (NASDAQ: GEVO), a leader in renewable fuels, chemicals and carbon management, today announced its financial results for the second